Compare HON & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HON | CI |
|---|---|---|
| Founded | 1885 | 1792 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.9B | 76.8B |
| IPO Year | 2011 | 2018 |
| Metric | HON | CI |
|---|---|---|
| Price | $245.39 | $283.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 14 |
| Target Price | $250.45 | ★ $346.07 |
| AVG Volume (30 Days) | ★ 3.4M | 1.7M |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | 1.92% | ★ 2.15% |
| EPS Growth | N/A | ★ 83.00 |
| EPS | 7.36 | ★ 22.18 |
| Revenue | $36,529,000,000.00 | ★ $274,900,000,000.00 |
| Revenue This Year | $6.70 | $5.75 |
| Revenue Next Year | $5.70 | $5.90 |
| P/E Ratio | $33.64 | ★ $13.10 |
| Revenue Growth | ★ 12.92 | 11.24 |
| 52 Week Low | $179.36 | $239.51 |
| 52 Week High | $247.93 | $350.00 |
| Indicator | HON | CI |
|---|---|---|
| Relative Strength Index (RSI) | 64.79 | 49.62 |
| Support Level | $233.01 | $280.76 |
| Resistance Level | $245.63 | $289.03 |
| Average True Range (ATR) | 4.51 | 7.01 |
| MACD | -0.82 | -0.34 |
| Stochastic Oscillator | 61.06 | 46.20 |
Honeywell traces its roots to 1885 with Albert Butz's firm, Butz Thermo-Electric Regulator, which produced a predecessor to the modern thermostat. Other inventions by Honeywell include biodegradable detergent and autopilot. Today, Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. It operates through four business segments: aerospace technologies, industrial automation, energy and sustainability solutions, and building automation. Recently, Honeywell has made several portfolio changes to focus on fewer end markets and align with a set of secular growth trends. The firm is working diligently to expand its installed base, deriving around one third of its revenue from recurring aftermarket services.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.